Cytomegalovirus gastritis after treatment with rituximab.
Hasegawa
Y
Y
Department of Gastroenterology, Kushiro City General Hospital, Kushiro, Japan.
Goto
A
A
Nishimura
S
S
Sukawa
Y
Y
Fujii
K
K
Suzuki
K
K
Yonezawa
K
K
Abe
T
T
Shinomura
Y
Y
Yoshida
Y
Y
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000139:chemically induced*; D016145:Endoscopy, Digestive System; D005260:Female; D005756:Gastritis / Q000139:chemically induced* / Q000821:virology; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab